Refining the prognostic impact of the cell of origin in diffuse large B-cell lymphoma
- 1 May 2017
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 28 (5), 918-920
- https://doi.org/10.1093/annonc/mdx133
Abstract
No abstract availableFunding Information
- Ministerio de Economía y Competitividad (SAF2015-64885-R)
- Generalitat de Catalunya Suport Grups de Recerca (AGAUR 2014-SGR-795)
This publication has 26 references indexed in Scilit:
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologistsPathology, 2015
- The Genetic Landscape of Diffuse Large B-Cell LymphomaSeminars in Hematology, 2015
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classificationBlood, 2013
- Diffuse large B-cell lymphoma—treatment approaches in the molecular eraNature Reviews Clinical Oncology, 2013
- New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphomaBest Practice & Research Clinical Haematology, 2012
- BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and RituximabClinical Cancer Research, 2011
- The molecular biology of diffuse large B-cell lymphomaTherapeutic Advances in Hematology, 2011
- Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory responseBlood, 2005
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaThe New England Journal of Medicine, 2002